Literature DB >> 21764337

A comparative study of health related quality of life, psychological well-being, impact of illness and stigma in epilepsy and migraine.

Nuran Aydemir1, Ciğdem Ozkara, Pınar Unsal, Reşit Canbeyli.   

Abstract

This study aimed to show the difference of epilepsy from another chronic neurological disorder with episodic manifestations (CDEM): migraine. Seventy persons with epilepsy (PWE), 56 persons with migraine (PWM) and 45 healthy control participants (HCs) were included. The groups were compared in terms of demographics, quality of life, depression and self-esteem. The PWE and PWM were also compared with regard to stigma, impact of the illness, disclosure, application of spiritual/traditional healing methods, limitations, most affected life areas, and restrictions. Results showed that the PWM had lower quality of life values than the PWE and the HCs, while there was no difference among the groups in depression and self-esteem. Results also show higher unemployment levels and lower marriage rates for the PWE, where education levels were equal. Although the PWM had higher impact of illness values, the PWE were shown to have higher stigma, more concealment behavior, and higher traditional/spiritual healing application ratios. Also, the PWM emphasized the importance of being "able to fulfil daily living, social and work activities", while the PWE emphasized the need for "independence" constantly. These results indicate that, although both migraine and epilepsy are CDEMs, they have different levels of impact on patients' lives. The impacts are socially greater in epilepsy and extend beyond the neurological condition itself.
Copyright © 2011 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21764337     DOI: 10.1016/j.seizure.2011.06.017

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


  16 in total

1.  Stigma perceptions in patients with eosinophilic gastrointestinal disorders.

Authors:  L Guadagnoli; T H Taft; L Keefer
Journal:  Dis Esophagus       Date:  2017-07-01       Impact factor: 3.429

Review 2.  Migraine: Stigma in Society.

Authors:  Simy K Parikh; William B Young
Journal:  Curr Pain Headache Rep       Date:  2019-02-09

3.  Quality of life assessment in migraine and relapsing remitting multiple sclerosis: self-perceived health is similar.

Authors:  Klaudia Duka Glavor; Marina Titlić; Gorka Vuletić; Anamarija Mrđen; Marina Maras Šimunić
Journal:  Neurol Sci       Date:  2019-07-17       Impact factor: 3.307

4.  An invisible cause of disability: stigma in migraine and epilepsy.

Authors:  Fulya Basoglu Koseahmet; Burcu Polat; R Gokcen Gozubatik-Celik; Isil Baytekin; Muazzez Gokcen Soylu; Ayten Ceyhan Dirican; Musa Ozturk
Journal:  Neurol Sci       Date:  2022-01-15       Impact factor: 3.307

5.  Validation and Reliability Study of the Turkish Version of the Stigma Scale of Epilepsy.

Authors:  Nevin Kuloğlu Pazarci; Nihan Parasiz Yükselen; Şenay Aydın; Zeynep Ünlüsoy Acar; Dilek Necioğlu Örken
Journal:  Noro Psikiyatr Ars       Date:  2017-12       Impact factor: 1.339

6.  Epilepsy, mental health disorder, or both?

Authors:  Vadim Beletsky; Seyed M Mirsattari
Journal:  Epilepsy Res Treat       Date:  2011-12-15

7.  Meta-analysis of the relationship between multiple sclerosis and migraine.

Authors:  Julia Pakpoor; Adam E Handel; Gavin Giovannoni; Ruth Dobson; Sreeram V Ramagopalan
Journal:  PLoS One       Date:  2012-09-14       Impact factor: 3.240

8.  Family functioning, marital quality and social support in Chinese patients with epilepsy.

Authors:  Yi-he Wang; Michelle Haslam; Ming Yu; Juan Ding; Qian Lu; Fang Pan
Journal:  Health Qual Life Outcomes       Date:  2015-01-28       Impact factor: 3.186

9.  The stigma of migraine.

Authors:  William B Young; Jung E Park; Iris X Tian; Joanna Kempner
Journal:  PLoS One       Date:  2013-01-16       Impact factor: 3.240

Review 10.  A systematic review of disease-related stigmatization in patients living with inflammatory bowel disease.

Authors:  Tiffany H Taft; Laurie Keefer
Journal:  Clin Exp Gastroenterol       Date:  2016-03-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.